Pharma: Other News To Note
• Shire plc, of Dublin, Ireland, said the European Committee for Medicinal Products for Human Use approved the production of Vpriv (velaglucerase alfa) in the firm's new manufacturing facility in Lexington, Mass. The European Commission's decision is expected shortly. Vpriv is an enzyme replacement therapy marketed for Gaucher disease.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter